Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

JPMorgan Chase & Co. has raised its price target for Merck & Co., Inc. (NYSE:MRK) to $135 from $125, maintaining an “overweight” rating and suggesting an 11.8% upside. This follows Merck’s strong Q4 2025 earnings beat, with EPS of $2.04 and revenue of $16.40 billion, surpassing analyst expectations. The company also provided optimistic FY2026 EPS guidance, while institutional investors have significantly increased their holdings despite some insider selling.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin